{"title":"Introductory Chapter: Nature’s Ancient Nanomachines and Their Synthetic Future","authors":"R. Savva","doi":"10.5772/intechopen.90384","DOIUrl":"https://doi.org/10.5772/intechopen.90384","url":null,"abstract":"Bacteriophages are generally considered to be the most prevalent biological entities on planet Earth [1], with astronomical estimates of their myriad abundance. These fascinatingly diverse viruses, which infect bacterial cells, were discovered in the second decade of the twentieth century. Under the light microscope, bacterial cells were seen to be apparently eaten away, hence the scientific Greek naming of these viruses meaning literally “bacteria eaters”. The middle decades of that century gave us a first glimpse of these viral particles, via their imaging using the technique of negative stain electron microscopy. The morphology of the first studied particles was symbolic of the so-called Space Age in which these discoveries took place: The archetypal Phi X 174 evoked the first artificial satellites, while the T-even phages resembled prototypic lunar landing vehicles. Such latter-day futuristic symbolismmay seem amusingly outdated by the time of writing. However, the undoubtedly ancient bacteriophages are now riding a new wave of technological advancement: synthetic biology. Interestingly, this returns us to the potential revolution in healthcare that surrounded the initial discovery of bacteriophages. The simple fact is that phages, which is a common abbreviation used when referring to these viruses, are capable of selective killing of bacterial cells of a given species or strain. In other words, phages are exquisitely specific microbial control agents. In the current antimicrobial resistance era [2], exemplified by the ESKAPE organisms, which is to name only the vanguard of untreatable pathogenic microbes, phages offer a potential panacea for the treatment of pathogenic bacterial infection. Indeed, deployment of phages to treat bacterial infections in animals and humans was the first exploitative use of these virus entities. Their promise as therapeutic agents was, nevertheless, soon eclipsed by the rise of antibiotics. However, partly by economic necessity, the refinement of such phage-mediated treatments persisted in the former USSR [3]. Today, the fruit of that legacy provides effective alternative treatment in an era of antibiotic-resistant microorganisms [4]. Including the long-standing cases of treatment achieved within the pioneering hospitals in the former Soviet territory of Georgia [5], there have also been recent high-profile cases [6], as well as a rise in commercial offerings based upon sound scientific discovery [7].","PeriodicalId":302364,"journal":{"name":"Bacteriophages - Perspectives and Future","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121484016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Biotechnology Tools Derived from the Bacteriophage/Bacteria Arms Race","authors":"Vitor B. Pinheiro","doi":"10.5772/intechopen.90367","DOIUrl":"https://doi.org/10.5772/intechopen.90367","url":null,"abstract":"The long association and intense competition between bacteria and their viruses have created a fertile ground for evolution to develop numerous tools for DNA modification, assembly and degradation. Many of these tools underpin the past 50 years of molecular biology, and others show great potential in shaping the next 50 years of the field. Here, I present some of the tools that have come out of the bacteria-bacteriophage arms race and discuss some of the concepts that may shape their future use. Molecular biology remains a fast-growing area increasingly limited solely by researcher ingenuity.","PeriodicalId":302364,"journal":{"name":"Bacteriophages - Perspectives and Future","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128029744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Ward, S. Branston, E. Stanley, E. Keshavarz‐Moore
{"title":"Scale-Up and Bioprocessing of Phages","authors":"J. Ward, S. Branston, E. Stanley, E. Keshavarz‐Moore","doi":"10.5772/INTECHOPEN.88275","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.88275","url":null,"abstract":"A profusion of new applications for phage technologies has been developed within the last few years, stimulating investigations into the large-scale production of different phages. Applications such as antibiotic replacement, phages as gene therapy vectors, phages as vaccines, diagnostics using filamentous phages and novel optical applications such as the phage laser may need grams to kilogrammes of phage in the future. However, many of the techniques that are used for the growth and purification of bacteriophage at small scale are not transferable to large-scale production facilities of phage in industrial processes. In this chapter, the stages of production that need to be carried out at scale are examined for the efficient large-scale fermentation of the filamentous phage M13 and the Siphoviridae phage lambda ( λ ). A number of parameters are discussed: the multiplicity of infection (MOI) of phage to host cells, the impact of agitation on the initial infection stages, the co-growth with phage rather than static attachment, the use of engineered host cells expressing nuclease, the optimisation of both the quantity and the physiology of the E. coli inoculum and phage precipitation methods.","PeriodicalId":302364,"journal":{"name":"Bacteriophages - Perspectives and Future","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126362850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Unusual Linear Plasmid Generating Systems of Prokaryotes","authors":"Sophie E. Knott, S. A. Milsom, P. Rothwell","doi":"10.5772/INTECHOPEN.86882","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.86882","url":null,"abstract":"Linear DNA is vulnerable to exonuclease degradation and suffers from genetic loss due to the end replication problem. Eukaryotes overcome these problems by locating repetitive telomere sequences at the end of each chromosome. In humans and other vertebrates this noncoding terminal sequence is repeated between hundreds and thousands of times, ensuring important genetic information is protected. In most prokaryotes, the end-replication problem is solved by utilizing circular DNA molecules as chromosomes. However, some phage and bacteria do store genetic information in linear constructs, and the ends of these structures form either invertrons or hairpin telomeres. Hairpin telomere formation is catalyzed by a protelomerase, a unique protein that modifies DNA by a two-step transesterification reaction, proceeding via a covalent protein bound intermediate. The specifics of this mechanism are largely unknown and conflicting data suggests variations occur between different systems. These proteins, and the DNA constructs they produce, have valuable applications in the biotechnology industry. They are also an essential component of some human pathogens, an increased understanding of how they operate is therefore of fundamental importance. Although this review will focus on phage encoded protelomerase, protelomerases found from Agrobacterium and Borellia will be discussed in terms of mechanism of action.","PeriodicalId":302364,"journal":{"name":"Bacteriophages - Perspectives and Future","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131838272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bacteriophages: Their Structural Organisation and Function","authors":"H. White, E. Orlova","doi":"10.5772/INTECHOPEN.85484","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.85484","url":null,"abstract":"Viruses are infectious particles that exist in a huge variety of forms and infect practically all living systems: animals, plants, insects and bacteria. Viruses that infect and use bacterial resources are classified as bacteriophages (or phages) and represent the most abundant life form on Earth. A phage can be described as a specific type of nano-machine that is able to recognise its environment, find a host cell, start infection, self-assemble and safeguard its genome until the next cycle of replication is initiated. Remarkable results have been obtained by combining cryo-EM, X-ray analysis and bioinformatics in structural studies of these nano-machines. In this review we will describe results of structural studies of phages that uncover their organisation in different conformations, thus facilitating our understanding of the functional mechanisms in supramolecular assemblies and helping us understand the usage of phages in medical treatments. Currently, antibiotic resistance is an enormous challenge that we face. The tailed phages could be used in place of antibiotics due to their high specificity to host cells, but more knowledge of their organisation and function is required.","PeriodicalId":302364,"journal":{"name":"Bacteriophages - Perspectives and Future","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116735283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Targeting Peptides Derived from Phage Display for Clinical Imaging","authors":"S. Khondee, W. Piyawattanametha","doi":"10.5772/INTECHOPEN.84281","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.84281","url":null,"abstract":"Phage display is a high-throughput technology used to identify peptides or proteins with high and specific binding affinities to a target, which is usually a protein biomarker or therapeutic receptor. In general, this technique allows peptides with a particular sequence to be presented on a phage particle. Peptides derived from phage display play an important role in drug discovery, drug delivery, cancer imaging, and treatment. Phage peptides themselves can act as sole therapeutics, for example, drugs, gene therapeutic, and immunotherapeutic agents that are com-prehensively described elsewhere. In this chapter, we discuss phage selection and screening procedures in detail including some modifications to reduce nonspecific binding. In addition, the rationale for discovery and utilization of phage peptides as molecular imaging probes is focused upon. Molecular imaging is a new paradigm that uses advanced imaging instruments integrated with specific molecular imaging probes. Applications include monitoring of metabolic and molecular functions, therapeutic response, and drug efficacy, as well as early cancer detection, personalized medicine, and image-guided therapy.","PeriodicalId":302364,"journal":{"name":"Bacteriophages - Perspectives and Future","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130975463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Surveillance and Elimination of Bacteriophage Contamination in an Industrial Fermentation Process","authors":"J. Zahn, M. Halter","doi":"10.5772/INTECHOPEN.81151","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.81151","url":null,"abstract":"Commercial fermentation processes are often vulnerable to bacteriophage due to the lack of genetic diversity and use of high cell density cultures. Bacteriophage infections in these fermentations can have adverse impacts on operability of the production facility and product quality and prevent recovery of valuable bioprod-ucts in the downstream process. Prevention strategies have been developed and optimized through feedback from bacteriophage diagnostic tests, which inform improvements to process design for elimination of entry points, as well as modification of the biocatalyst to reduce or eliminate bacteriophage virulence. In this chapter, we provide case studies for successful elimination of bacteriophage virulence via host modifications, including bacteriophage binding-site modifications on the outer membrane of an Escherichia coli production host, used for commercial manufacture of 1,3-propanediol, as well as application of CRISPR-associated protein 9 (Cas9) for bacteriophage immunity. Finally, we report application of bacteriophage diagnostic methods to fully characterize and eliminate bacteriophage entry points in a commercial fermentation process.","PeriodicalId":302364,"journal":{"name":"Bacteriophages - Perspectives and Future","volume":"103 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123538339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}